; and (2) ensure that any entity that provides pharmacy benefits management services under a contract with any such health plan or health insurance coverage does not, with respect to such plan or coverage, restrict, directly or indirectly, a pharmacy that dispenses a prescription drug from informing (or penalize such pharmacy for informing) an enrollee of any differential between the enrollee's out-of-pocket cost under such plan or coverage with respect to acquisition of the drug and the amount an individual would pay for acquisition of the drug without using any group health plan or health insurance coverage. (b) Definition For purposes of this section, the term out-of-pocket cost , with respect to acquisition of a drug, means the amount to be paid by the enrollee under the plan or coverage, including any cost-sharing (including any deductible, copayment, or coinsurance) and, as determined by the Secretary, any other expenditure. . (2) Conforming amendment Section 2729 of the Public Health Service Act ( 42 U.S.C. 300gg–29 ) is amended by adding at the end the following new subsection: (c) Sunset The preceding provisions of this section shall not apply beginning on the date of the enactment of this subsection. . (b) ERISA (1) In general Subpart B of part 7 of Subtitle B of title I of the Employee Retirement Income Security Act of 1974 ( 29 U.S.C. 1185 et seq. ), as amended by section 106, is further amended by adding at the end the following new section: 727. Information on prescription drugs (a) In general A group health plan or a health insurance issuer offering group health insurance coverage shall— (1) not restrict, directly or indirectly, any pharmacy that dispenses a prescription drug to a participant or beneficiary in the plan or coverage from informing (or penalize such pharmacy for informing) a participant or beneficiary of any differential between the participant’s or beneficiary’s out-of-pocket cost under the plan or coverage with respect to acquisition of the drug and the amount an individual would